• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Cancer-focused Liminatus sets out to test SPAC waters

cafead

Administrator
Staff member
  • cafead   Dec 02, 2022 at 11:42: AM
via SPAC deals are creeping back into the mainstream, with Liminatus Pharma and Iris Acquisition Corp. becoming the latest in the biotech sphere to test the waters.

article source
 

<